Scribe Therapetics co-founder and vice president of platform Brett Staahl (left) and co-founder and CEO Benjamin Oakes (right). Photo by Scribe Therapeutics.
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.